1. Home
  2. TVTX vs KMT Comparison

TVTX vs KMT Comparison

Compare TVTX & KMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TVTX
  • KMT
  • Stock Information
  • Founded
  • TVTX 2008
  • KMT 1938
  • Country
  • TVTX United States
  • KMT United States
  • Employees
  • TVTX N/A
  • KMT N/A
  • Industry
  • TVTX Biotechnology: Pharmaceutical Preparations
  • KMT Industrial Machinery/Components
  • Sector
  • TVTX Health Care
  • KMT Industrials
  • Exchange
  • TVTX Nasdaq
  • KMT Nasdaq
  • Market Cap
  • TVTX 1.7B
  • KMT 1.4B
  • IPO Year
  • TVTX N/A
  • KMT N/A
  • Fundamental
  • Price
  • TVTX $20.44
  • KMT $20.74
  • Analyst Decision
  • TVTX Strong Buy
  • KMT Hold
  • Analyst Count
  • TVTX 14
  • KMT 5
  • Target Price
  • TVTX $33.31
  • KMT $25.20
  • AVG Volume (30 Days)
  • TVTX 1.6M
  • KMT 972.8K
  • Earning Date
  • TVTX 05-01-2025
  • KMT 05-07-2025
  • Dividend Yield
  • TVTX N/A
  • KMT 3.88%
  • EPS Growth
  • TVTX N/A
  • KMT 2.33
  • EPS
  • TVTX N/A
  • KMT 1.38
  • Revenue
  • TVTX $273,533,000.00
  • KMT $1,993,706,000.00
  • Revenue This Year
  • TVTX $68.31
  • KMT N/A
  • Revenue Next Year
  • TVTX $55.65
  • KMT $1.66
  • P/E Ratio
  • TVTX N/A
  • KMT $14.29
  • Revenue Growth
  • TVTX 75.65
  • KMT N/A
  • 52 Week Low
  • TVTX $6.01
  • KMT $17.30
  • 52 Week High
  • TVTX $25.29
  • KMT $32.18
  • Technical
  • Relative Strength Index (RSI)
  • TVTX 61.49
  • KMT 59.68
  • Support Level
  • TVTX $19.84
  • KMT $19.42
  • Resistance Level
  • TVTX $22.07
  • KMT $21.25
  • Average True Range (ATR)
  • TVTX 1.11
  • KMT 0.64
  • MACD
  • TVTX 0.42
  • KMT 0.23
  • Stochastic Oscillator
  • TVTX 77.85
  • KMT 83.60

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

About KMT Kennametal Inc.

Kennametal Inc is a manufacturer of metalworking tools and wear-resistant engineered components and coatings. The company operates in two business segments; Metal Cutting and Infrastructure. It generates maximum revenue from the Metal Cutting segment. The Metal Cutting segment develops and manufactures high-performance tooling and metal cutting products and services and offers an assortment of standard and custom metal cutting solutions to diverse end markets, including aerospace, general engineering, energy, and transportation. Geographically, it derives maximum revenue from the United States and the rest from Germany, China, Canada, India, Italy, and other countries.

Share on Social Networks: